beta Thalassemia
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Five beta-thalassaemia heterozygotes, who were homozygous for the extra (TA) bases in the A(TA)nTAA element of the promoter of UGT-1A, the configuration present in homozygosity in Gilbert's syndrome, had higher bilirubin levels compared to those with the (TA)6/(TA)7 or (TA)6/(TA)6 configurations.
|
9375768 |
1997 |
beta^+^ Thalassemia
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Five beta-thalassaemia heterozygotes, who were homozygous for the extra (TA) bases in the A(TA)nTAA element of the promoter of UGT-1A, the configuration present in homozygosity in Gilbert's syndrome, had higher bilirubin levels compared to those with the (TA)6/(TA)7 or (TA)6/(TA)6 configurations.
|
9375768 |
1997 |
Crigler Najjar syndrome, type 1
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
The most severe syndrome, termed Crigler-Najjar syndrome type I, is mainly associated with mutations in exons 2 to 5 that affect all UGT1 enzymes and many of the mutations result in termination codons and frameshifts.
|
9435989 |
1997 |
Unconjugated hyperbilirubinemia
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Here we describe genetic defects that occur in the UGT1 gene complex that cause three non-haemolytic unconjugated hyperbilirubinaemia syndromes.
|
9435989 |
1997 |
Familial (FPAH)
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias.
|
9435989 |
1997 |
Carcinoma of lung
|
0.020 |
Biomarker
|
disease |
BEFREE |
Previously, two modes of expression of the isoform have been described: in colon carcinoma Caco-2 cells UGT1A6 was found to be TCDD-inducible, whereas in lung carcinoma A549 cells it was constitutively expressed.
|
9466822 |
1998 |
Colon Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Previously, two modes of expression of the isoform have been described: in colon carcinoma Caco-2 cells UGT1A6 was found to be TCDD-inducible, whereas in lung carcinoma A549 cells it was constitutively expressed.
|
9466822 |
1998 |
Hyperbilirubinemia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Elucidation of both the structure of the UGT1 gene complex, and the Mrp2 (cMoat) gene which encodes the canalicular conjugate export pump, has led to a greater understanding of the genetic basis of hyperbilirubinemia.
|
9748558 |
1998 |
Gilbert Disease (disorder)
|
0.200 |
Biomarker
|
disease |
BEFREE |
The recent identification of a variant promoter in the gene encoding for the bilirubin uridine-diphosphoglucuronosyl-transferase (UGT-1 A) associated with Gilbert's syndrome, allowed us to explore whether the presence of this variant promoter is a risk factor for the development of neonatal hyperbilirubinemia in normal newborns and in association with G6PD deficiency.
|
10541948 |
1999 |
Hyperbilirubinemia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
This finding indicates that the variant promoter of UGT-1 A does not contribute to the development of hyperbilirubinemia in the newborn.
|
10541948 |
1999 |
Hyperbilirubinemia, Neonatal
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
The recent identification of a variant promoter in the gene encoding for the bilirubin uridine-diphosphoglucuronosyl-transferase (UGT-1 A) associated with Gilbert's syndrome, allowed us to explore whether the presence of this variant promoter is a risk factor for the development of neonatal hyperbilirubinemia in normal newborns and in association with G6PD deficiency.
|
10541948 |
1999 |
Deficiency of glucose-6-phosphate dehydrogenase
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
The recent identification of a variant promoter in the gene encoding for the bilirubin uridine-diphosphoglucuronosyl-transferase (UGT-1 A) associated with Gilbert's syndrome, allowed us to explore whether the presence of this variant promoter is a risk factor for the development of neonatal hyperbilirubinemia in normal newborns and in association with G6PD deficiency.
|
10541948 |
1999 |
Gilbert Disease (disorder)
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
In one patient an unusually high plasma bilirubin level was associated with the variant A[TA]7TAA configuration in the TATA box of the uridine diphosphate glucuronosyltransferase (UGT-1A) gene promoter, the mutation found in most patients with mild Gilbert's syndrome.
|
10583252 |
1999 |
Crigler Najjar syndrome, type 1
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Lesions in the gene encoding bilirubin-UGT(1), lead to complete or partial inactivation of the enzyme causing the rare autosomal recessively inherited conditions, Crigler-Najjar syndrome type-1 (CN-1) and type 2 (CN-2), respectively.
|
11013440 |
2000 |
Malignant Neoplasms
|
0.030 |
GeneticVariation
|
group |
BEFREE |
Bilirubin UDP-glucuronosyltransferase 1A1 gene polymorphisms: susceptibility to oxidative damage and cancer?
|
11170257 |
2000 |
Primary malignant neoplasm
|
0.030 |
GeneticVariation
|
group |
BEFREE |
Bilirubin UDP-glucuronosyltransferase 1A1 gene polymorphisms: susceptibility to oxidative damage and cancer?
|
11170257 |
2000 |
Crigler Najjar syndrome, type 1
|
0.200 |
GeneticVariation
|
disease |
CLINVAR |
Crigler-Najjar syndrome type II resulting from three different mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.
|
11182932 |
2000 |
Colon adenoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk.
|
11325819 |
2001 |
Cholelithiasis
|
0.180 |
Biomarker
|
disease |
BEFREE |
These results suggest that the UGT*1 genotpe is of importance in the genesis of gallstones in this population of patients.
|
11425418 |
2001 |
Cholecystolithiasis
|
0.040 |
Biomarker
|
disease |
BEFREE |
These results suggest that the UGT*1 genotpe is of importance in the genesis of gallstones in this population of patients.
|
11425418 |
2001 |
Gilbert Disease (disorder)
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Its incidence was higher (P < 0.05) in patients homozygous for the (TA7) motif in the promoter of the UGT1-A1 gene, the genotype associated with Gilbert's syndrome, which seems to be a risk factor for the development of gallstones in TM and TI patients.
|
11843828 |
2001 |
Cholelithiasis
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
Its incidence was higher (P < 0.05) in patients homozygous for the (TA7) motif in the promoter of the UGT1-A1 gene, the genotype associated with Gilbert's syndrome, which seems to be a risk factor for the development of gallstones in TM and TI patients.
|
11843828 |
2001 |
Cholecystolithiasis
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Its incidence was higher (P < 0.05) in patients homozygous for the (TA7) motif in the promoter of the UGT1-A1 gene, the genotype associated with Gilbert's syndrome, which seems to be a risk factor for the development of gallstones in TM and TI patients.
|
11843828 |
2001 |
Cooley's anemia
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Its incidence was higher (P < 0.05) in patients homozygous for the (TA7) motif in the promoter of the UGT1-A1 gene, the genotype associated with Gilbert's syndrome, which seems to be a risk factor for the development of gallstones in TM and TI patients.
|
11843828 |
2001 |
Gilbert Disease (disorder)
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Both parameters were related to UDP-glucuronosyltransferase 1A1 (UGT) promoter polymorphism, associated with Gilbert's syndrome, in term male newborns.
|
11915038 |
2002 |